121 related articles for article (PubMed ID: 2441086)
1. [An immunohistochemical study of various breast tissues using CA15-3 (MAb 115D8 and MAb DF3)].
Sekine H
Gan No Rinsho; 1987 Jul; 33(8):913-9. PubMed ID: 2441086
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
[TBL] [Abstract][Full Text] [Related]
5. [A study of the clinical usefulness of the CA15-3 radioimmunoassay kit].
Abe Y; Odagiri E; Jibiki K; Demura R; Demura H
Gan No Rinsho; 1988 Oct; 34(12):1672-6. PubMed ID: 3193612
[TBL] [Abstract][Full Text] [Related]
6. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
[TBL] [Abstract][Full Text] [Related]
8. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
[TBL] [Abstract][Full Text] [Related]
9. [Different expressions of various epitopes of the Thomsen-Friedenreich antigen in breast cancer cells. Immunohistochemical study with monoclonal antibodies against asialoglycophorin A].
Bein G; Poschmann A; Seitz RC; Böcker W
Verh Dtsch Ges Pathol; 1985; 69():218-21. PubMed ID: 2420088
[No Abstract] [Full Text] [Related]
10. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
11. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
12. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.
Sekine H; Ohno T; Kufe DW
J Immunol; 1985 Nov; 135(5):3610-5. PubMed ID: 4045199
[TBL] [Abstract][Full Text] [Related]
14. [Thomsen antigen in human normal and tumor tissues].
Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
Biull Eksp Biol Med; 1983 Mar; 95(3):59-61. PubMed ID: 6830988
[TBL] [Abstract][Full Text] [Related]
15. [The immunohistochemical localization of CA 15-3 in human breasts and their tumors].
Ishikawa T; Tanaka Y; Sugihara K; Hatano M; Kaneko A; Motoji K; Nasu M; Okayasu I; Sato T; Inaba N
Gan No Rinsho; 1988 Mar; 34(3):277-82. PubMed ID: 2833635
[TBL] [Abstract][Full Text] [Related]
16. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22.
Croghan GA; Papsidero LD; Valenzuela LA; Nemoto T; Penetrante R; Chu TM
Cancer Res; 1983 Oct; 43(10):4980-8. PubMed ID: 6349797
[TBL] [Abstract][Full Text] [Related]
18. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.
Kufe D; Inghirami G; Abe M; Hayes D; Justi-Wheeler H; Schlom J
Hybridoma; 1984; 3(3):223-32. PubMed ID: 6094338
[TBL] [Abstract][Full Text] [Related]
19. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
Akewanlop C; Watanabe M; Singh B; Walker M; Kufe DW; Hayes DF
Cancer Res; 2001 May; 61(10):4061-5. PubMed ID: 11358826
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
